We are live on ! Find out more
MLNT

Melinta Therapeutics, Inc. Common Stock
MLNT

Delisted

MLNT was delisted on the 10th of January, 2020.

Back to rankings

2 hedge funds and large institutions have $0 invested in Melinta Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% less funds holding

Funds holding: 37 → 2 (-35)

97% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 33

100% less capital invested

Capital invested by funds: $584K → $0 (-$584K)

Holders
2
Holders Change
-35
Holders Change %
-94.59%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
33
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
-$239K

Top Buyers

Rank Fund Capital Flow
1
MPWT
MassMutual Private Wealth & Trust
Connecticut
+$16

Top Sellers

Rank Fund Capital Flow
1
Stifel Financial
Stifel Financial
Missouri
-$142K
2
GIM
Granahan Investment Management
Massachusetts
-$128K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$60K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$52K
5
Citadel Advisors
Citadel Advisors
Florida
-$30K
Name Holding Trade Value Shares
Change 		Change in
Stake
Stifel Financial
1
Stifel Financial
Missouri
– -$142K -267,582 Closed
GIM
2
Granahan Investment Management
Massachusetts
– -$128K -241,853 Closed
Geode Capital Management
3
Geode Capital Management
Massachusetts
– -$60K -113,002 Closed
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
– -$52K -98,622 Closed
Citadel Advisors
5
Citadel Advisors
Florida
– -$30K -56,839 Closed
CCM
6
Condor Capital Management
New Jersey
– -$23K -43,000 Closed
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
– -$22K -41,221 Closed
Group One Trading
8
Group One Trading
Illinois
– -$18K -33,406 Closed
OAM
9
Oxford Asset Management
United Kingdom
– -$15K -28,380 Closed
ARTA
10
A.R.T. Advisors
New York
– -$14K -26,356 Closed
Cetera Investment Advisers
11
Cetera Investment Advisers
Illinois
– -$12K -24,180 Closed
New York State Common Retirement Fund
12
New York State Common Retirement Fund
New York
– -$10K -18,413 Closed
Northern Trust
13
Northern Trust
Illinois
– -$9K -17,495 Closed
BlackRock
14
BlackRock
New York
– -$9K -17,373 Closed
IFG
15
Investors Financial Group
Minnesota
– -$9K -16,439 Closed
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
– -$8K -14,335 Closed
Morgan Stanley
17
Morgan Stanley
New York
– -$6K -10,412 Closed
PAI
18
Palo Alto Investors
California
– -$5K -10,137 Closed
Bank of Montreal
19
Bank of Montreal
Ontario, Canada
– -$3K -5,500 Closed
Bank of America
20
Bank of America
North Carolina
– -$1K -1,610 Closed
BNP Paribas Financial Markets
21
BNP Paribas Financial Markets
France
– -$22 -41 Closed
MPWT
22
MassMutual Private Wealth & Trust
Connecticut
– +$16 +30 New

MLNT Hedge Fund Activity: Q1 2020 in Review

2 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Melinta Therapeutics, Inc. Common Stock (MLNT) for Q1 2020, worth a combined $0 — down 100% from $584K a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of MLNT and 1 opened new positions — a net loss of 32 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was MassMutual Private Wealth & Trust, opening a new position worth an estimated $16. The largest seller was Stifel Financial, exiting entirely with an estimated $142K sold.

  • 2 institutional investors held Melinta Therapeutics, Inc. Common Stock (MLNT) as of Q1 2020, down from 37 in Q4 2019.
  • Funds reported $0 of Melinta Therapeutics, Inc. Common Stock stock for Q1 2020, down 100% quarter-over-quarter.
  • 1 fund opened new Melinta Therapeutics, Inc. Common Stock positions in Q1 2020 and 33 closed out, a net change of -32 holders.
  • The largest Melinta Therapeutics, Inc. Common Stock buyer in Q1 2020 was MassMutual Private Wealth & Trust, an estimated $16 added.
  • The largest Melinta Therapeutics, Inc. Common Stock seller in Q1 2020 was Stifel Financial, an estimated $142K sold.

Based on aggregated 13F filings for Q1 2020.